A systematic review of live vaccine outcomes in infants exposed to biologic disease modifying anti-rheumatic drugs in utero.

Goulden, Bethan; Chua, Nicole; Parker, Elaine; Giles, Ian

A systematic review of live vaccine outcomes in infants exposed to biologic disease modifying anti-rheumatic drugs in utero.

Goulden, Bethan; Chua, Nicole; Parker, Elaine; Giles, Ian.

Affiliation

Goulden B; Department of Rheumatology.
Chua N; General Medicine Department, University College London Hospital.
Parker E; General Medicine Department, University College London Hospital.
Giles I; Centre for Rheumatology, Department of Inflammation, Division of Medicine, University College London, London, UK.

Rheumatology (Oxford) ; 61(10): 3902-3906, 2022 10 06.

Article in En | MEDLINE | ID: mdl-35258557

Subject(s)

Antirheumatic Agents; BCG Vaccine; Adalimumab; Antirheumatic Agents/adverse effects; BCG Vaccine/adverse effects; Etanercept; Humans; Infant; Infant, Newborn; Infliximab/therapeutic use; Tumor Necrosis Factor Inhibitors; Ustekinumab

Key words

DMARDs; RA; biological therapies; immunosuppressants; pregnancy and rheumatic disease

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: BCG Vaccine / Antirheumatic Agents Type of study: Guideline / Prognostic_studies / Systematic_reviews Limits: Humans / Infant / Newborn Language: En Journal: Rheumatology (Oxford) Journal subject: REUMATOLOGIA Year: 2022 Type: Article

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google